Leptin together with other cytokines, could be promising new biological markers and therapeutic targets in obesity-related diseases (Ghadge and Khaire, 2019; Bruno et al., 2021). This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.